Curcuma longa

In silico studies on the therapeutic potential of novel marker compounds isolated from chemically modified bioactive fraction from Curcuma longa (Non-carbonyl Curcuma longa)

Naqvi A, Al-Harbi RAK, Ali S, Malasoni R, Gupta S, Dwivedi AKumar. In silico studies on the therapeutic potential of novel marker compounds isolated from chemically modified bioactive fraction from Curcuma longa (Non-carbonyl Curcuma longa). Pharmacognosy Magazine [Internet]. 2021;17(74):263-267. http://www.phcog.com/text.asp?2021/17/74/263/321246

In Silico and In Vitro anticancer activity of isolated novel marker compound from chemically modified bioactive fraction from Curcuma longa (NCCL)

Naqvi A, Malasoni R, Gupta S, Srivastava A, Pandey RR, Dwivedi AKumar. In Silico and In Vitro anticancer activity of isolated novel marker compound from chemically modified bioactive fraction from Curcuma longa (NCCL). Pharmacognosy Magazine [Internet]. 2017;13(51s):s640-s644. https://www.ncbi.nlm.nih.gov/pubmed/29142426

Bioactive turmerosaccharides from Curcuma longa Extract (NR-INF-02): Potential ameliorating effect on osteoarthritis pain

Bethapudi B, Murugan S, Illuri R, Mundkinajeddu D, Velusami CChinampudu. Bioactive turmerosaccharides from Curcuma longa Extract (NR-INF-02): Potential ameliorating effect on osteoarthritis pain. Pharmacognosy Magazine [Internet]. 2017;13(51s):s623-s627. https://www.ncbi.nlm.nih.gov/pubmed/29142423
Subscribe to Curcuma longa